DermaPrecise @DermaPrecise

DermaPrecise is an electronic multi-needle dermal injector to be used when consistent precision over depth, dose, and delivery matters. Owned by @RepliCel. replicel.com/products/rci-02 Joined October 2021

Tweets

15
Followers

44
Following

70
Likes

31

AAD @AADskin

3 years ago

Hair loss is one of the most common conditions that dermatologists. Learn more: bit.ly/3x66KQF #HairLossAwarenessMonth

0 9 22 0 0

Download Image

DermaPrecise @DermaPrecise

3 years ago

The @RepliCel DermaPrecise Injector Shown to Produce Consistently High Cell Viability for Cell Therapy Injections. The Innovacell testing shows that DermaPrecise may greatly improve post-injection cell viability for injections into dermal or subcu tissue. accesswire.com/viewarticle.as…

0 1 1 0 0

DermaPrecise @DermaPrecise

3 years ago

As @RepliCel said, we're excited to share our first dermal injector data showing consistent injection and distribution in donated skin tissue. When injection precision matters, we believe @DermaPrecise will be the only and best solution for intra-dermal + sub-cutaneous injections

RepliCel Life Sciences Inc. @RepliCel

3 years ago

1 2 7 0 0

Download Image

0 1 4 0 0

RepliCel Life Sciences Inc. @RepliCel

3 years ago

Independent Laboratory Test Results Confirm Value of DermaPrecise (TM) Injection Consistency in Clinical Simulation Testing. accesswire.com/709732/Indepen… #dermtwitter #dermatology #dermalinjections #hairloss

3 2 5 0 0

The Dermatologist @TheDermEditor

4 years ago

The #eczema pipeline includes a number of biologic agents that target novel cytokines—IL-13 and IL-31. Watch April Armstrong, MD, MPH, discuss the evidence in this video: okt.to/70wXqF #dermtwitter #dermatology

0 1 2 0 0

DermaPrecise @DermaPrecise

4 years ago

Another great injectible approved. This one (by @LEOHealthySkin) for the treatment of the very painful atopic dermatitis. We are actively exploring the benefits of controlled, highly reproducible and precise, multi-needle dispersion for such treatment protocols.

Dermatology Times @DermTimesNow

4 years ago

0 1 7 0 0

0 0 3 0 0

RepliCel Life Sciences Inc. @RepliCel

4 years ago

The extracellular matrix under skin loses ~1% of its collagen per year. By age 45, we face ~25% collagen loss causing a loss of skin support structure and elasticity. RCS-01 is in development to stimulate new collagen production using a patient's own cells. #naturalregeneration

1 3 16 0 0

Download Image

Lt Col Ret MD David Perez-Meza FISHRS ABHRS @drdaviperezmeza

4 years ago

Very interesting article. There are so many variables with the MN and/or PRP techniques for hair loss. I do agree, a further research is needed. Thx for sharing.

Kevin McElwee @ResearchHair

4 years ago

Very interesting article. There are so many variables with the MN and/or PRP techniques for hair loss. I do agree, a further research is needed. Thx for sharing.

0 3 12 0 2

0 1 3 0 0

The Dermatologist @TheDermEditor

4 years ago

Prior to his session at Dermatology Week, Dr Hassan Galadari discussed updates in neuromodulators and injectable fillers including considerations on how to go about the procedures. Watch his discussion here: okt.to/eirFut #dermtwitter #cosmetic #dermatology

0 1 1 0 0

Download Image

AHMED ALZAMER @AHMEDALZAMER

4 years ago

@najla_aldawsari FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers fda.gov/news-events/pr…

1 1 1 0 1

DermaPrecise @DermaPrecise

4 years ago

It's not a product launch (yet) but its a product and we are pleased to be launching the trademark to start building pre-market awareness for the #dermalinjector we've developed for use with injections where precision matters. finance.yahoo.com/news/replicel-… @RepliCel @lifesciences_bc

1 1 5 0 0

Download Image

DermaPrecise @DermaPrecise

4 years ago

We are very pleased to announce the name and trademark for the @RepliCel dermal injector. DermaPrecise (tm) is an electronic multi-needle dermal injector to be used when consistent precision over depth, dose, and delivery matters. biospace.com/article/releas… via @biospace